OTUD7B Mediates IRF3 Degradation via SQSTM1/p62 Deubiquitination: Insights into Antiviral Immune Regulation

Study Background and Research Question

Innate antiviral immunity is the host's first defense against viral infections, relying on early recognition of viral components and the induction of type I interferons (IFNs). Key to this process is the transcription factor IRF3, whose activation and stability are tightly controlled by post-translational modifications, including ubiquitination and phosphorylation. Autophagy, particularly selective autophagy, is increasingly recognized as a critical regulator of immune responses, capable of degrading not only pathogens but also immune signaling proteins to maintain cellular homeostasis. Despite this, the molecular details governing the selective autophagic degradation of IRF3 remained incompletely understood. The recent study by Xie et al. (OTUD7B deubiquitinates SQSTM1/p62 and promotes IRF3 degradation) addresses this knowledge gap by investigating the role of the deubiquitinase OTUD7B in modulating IRF3 turnover and innate immune signaling.

Key Innovation from the Reference Study

The central innovation of this work lies in identifying OTUD7B as a negative regulator of antiviral immunity through its substrate-specific action on the cargo receptor SQSTM1/p62. OTUD7B was shown to directly interact with IRF3 and selectively remove K63-linked polyubiquitin chains from lysine 7 of SQSTM1/p62. This deubiquitination event promotes SQSTM1 oligomerization, thereby enhancing its ability to mediate autophagic degradation of IRF3. The study uniquely demonstrates that OTUD7B-driven deubiquitination modulates the activation state of a cargo receptor in a substrate-dependent manner, forming a negative feedback loop that tempers IFN signaling following viral infection.

Methods and Experimental Design Insights

To unravel these mechanisms, the authors combined molecular biology, cell biology, and biochemical techniques. Key experimental approaches included:

• Co-immunoprecipitation assays to determine protein-protein interactions among OTUD7B, IRF3, and SQSTM1/p62.
• Ubiquitination assays using K63-specific antibodies to track the modification status of SQSTM1/p62.
• Functional assays with virus-infected cells to monitor changes in OTUD7B expression, IRF3 stability, and downstream IFN responses.
• Loss- and gain-of-function experiments (siRNA knockdown and overexpression constructs) to confirm the necessity and sufficiency of OTUD7B activity.
• Use of autophagy inhibitors and mutant constructs to dissect the role of selective autophagy in IRF3 degradation.

The study also leveraged microscopy and oligomerization assays to directly visualize SQSTM1/p62 structural changes upon OTUD7B-mediated deubiquitination.

Core Findings and Why They Matter

Major findings from the study include:

• OTUD7B interacts with both IRF3 and SQSTM1/p62, with viral infection upregulating OTUD7B expression.
• Deubiquitination of SQSTM1/p62 at K7 by OTUD7B enhances its oligomerization, which is essential for cargo receptor function in selective autophagy.
• OTUD7B facilitates the autophagic degradation of IRF3, dampening type I IFN production and thereby acting as a negative feedback regulator of antiviral immunity.
• The study delineates a feedback loop: viral infection induces OTUD7B, which in turn promotes IRF3 turnover, ultimately balancing the magnitude and duration of the host antiviral response (reference).

These insights reveal how selective autophagy and deubiquitination intersect to fine-tune innate immune signaling, suggesting that targeting OTUD7B or the SQSTM1/p62–IRF3 axis could be therapeutically relevant for controlling excessive or chronic inflammation.

Comparison with Existing Internal Articles

Recent internal reviews on the 3X (DYKDDDDK) Peptide and its application in affinity purification of FLAG-tagged proteins provide complementary perspectives on the technical underpinnings of protein–protein interaction studies. For example, internal resources demonstrate how the 3X FLAG peptide enables robust immunodetection of FLAG fusion proteins and facilitates advanced workflows such as metal-dependent ELISA assay and protein crystallization with FLAG tag (see also).

While these internal articles focus on methodological innovations for the study of recombinant protein complexes and epitope tagging strategies, the reference study by Xie et al. illustrates biological mechanisms that can be interrogated using such tools. For instance, affinity purification of protein complexes containing OTUD7B or SQSTM1/p62 could be streamlined using advanced FLAG-tag systems, bridging technical and biological discovery.

Limitations and Transferability

Despite its mechanistic depth, the study's main limitation is its reliance on in vitro and cell-based models; in vivo validation of the OTUD7B–SQSTM1–IRF3 axis, especially in the context of complex immune responses or viral infections in animal models, remains to be fully explored. Additionally, while the work highlights a substrate-specific autophagy mechanism, transferability to other cargo receptors or immune signaling pathways may require further investigation. The findings are most directly applicable to contexts where precise modulation of type I IFN signaling is relevant, such as viral pathogenesis or immune homeostasis.

Protocol Parameters

• Co-immunoprecipitation conditions: Use mild, non-denaturing buffers to preserve OTUD7B–IRF3–SQSTM1/p62 interactions; include protease and deubiquitinase inhibitors as appropriate.
• Ubiquitination detection: Employ K63-linkage–specific antibodies for immunoblotting SQSTM1/p62.
• Autophagy modulation: Bafilomycin A1 (Baf A1) can be used (100 nM, 4–8 h) to block autophagic flux and assess IRF3 turnover.
• Viral infection: Use Sendai virus or VSV at defined MOI (e.g., MOI 1–5) to stimulate IFN signaling and OTUD7B induction.
• Affinity purification workflows: For FLAG-tagged protein complexes, apply 3X FLAG peptide elution (see product guidelines) to minimize disruption of protein–protein interactions.

Research Support Resources

Researchers aiming to dissect protein interactions or post-translational modifications described in this study may benefit from robust affinity purification and immunodetection tools. The 3X (DYKDDDDK) Peptide (SKU A6001) offers a reliable solution for isolating FLAG-tagged proteins, supporting workflows such as co-immunoprecipitation, protein crystallization with FLAG tag, and metal-dependent ELISA assays, as outlined in both the product specification and related internal resources. Its hydrophilic and structurally unobtrusive design is well-suited for preserving functional protein complexes, as required in studies like those of OTUD7B and SQSTM1/p62.